The trials will involve a total of 600 adults - half of whom have already received two doses of Moderna's Covid-19 vaccine at least six months ago, and half of whom have received two doses plus the previously authorised booster dose.
The company also reported results on the efficacy against Omicron of the booster that has already been authorised. These data were obtained by studying the blood of 20 people who received the 50 microgram booster, half the amount of the first two injections. "Nonetheless, given the long-term threat demonstrated by Omicron's immune escape, we are advancing our Omicron-specific variant vaccine booster candidate and we are pleased to begin this part of our Phase 2 study," Ms Bancel continued.
Thanks, but no thanks.
Stick it
Someone should tell them there's this wonder drug called paracetamol that does the same thing 👍🏻
Gotta catch them all 🤡
sailorrooscout hey, is there plans to actually roll this out if you know? Or just on a stand by if need be? TIA 🤗
oh ffs
Totally pointless business decision.
All for Money😂😂
Phones out of memory with all the certs
Comical really ,🤣you got to love those yanks ,the only thing they love more then the dollar ,is manufacturing useless juices